International Journal of STD & AIDS

International Journal of STD & AIDS
Title	International Journal of STD & AIDS
Discipline	Infectious diseases; Sexual health
Abbreviation	Int. J. STD AIDS
Publisher	Wiley-Blackwell
Country	United Kingdom
Frequency	Monthly
History	1990–present
Impact	(see Abstracting and indexing)

International Journal of STD & AIDS is a peer-reviewed medical journal focusing on sexually transmitted infections and acquired immune deficiency syndromes. It publishes original research, reviews, clinical reports, and policy analyses addressing diagnosis, treatment, prevention, and public health aspects of sexually transmitted diseases. The journal serves clinicians, researchers, and public health professionals engaged with HIV/AIDS and other sexually transmitted infections across global health systems.

History

The journal was established in 1990 during a period of intensive international activity on HIV/AIDS and World Health Organization initiatives, coinciding with major scientific milestones such as the development of antiretroviral therapy and international conferences like the International AIDS Conference. Early editorial leadership drew contributors linked to institutions including University College London, London School of Hygiene & Tropical Medicine, Imperial College London, and centers in United States such as Johns Hopkins University and University of California, San Francisco. Throughout the 1990s and 2000s the journal documented developments related to landmark events and programs including PEPFAR, UNAIDS, and the rollout of combination antiretroviral therapy regimens, alongside research emerging from sites such as South Africa, Brazil, India, Thailand, and Kenya.

Scope and content

Coverage spans clinical management of infections such as HIV/AIDS, syphilis, gonorrhea, chlamydia, herpes simplex virus, and human papillomavirus; translational research connected to entities like National Institutes of Health and Medical Research Council (United Kingdom); and public health analyses tied to programs from Centers for Disease Control and Prevention and Médecins Sans Frontières. The journal regularly publishes comparative trials, cohort studies, diagnostic studies involving technologies from firms such as Abbott Laboratories and Roche Diagnostics, and guideline-related commentary influenced by agencies like National Institute for Health and Care Excellence and European Centre for Disease Prevention and Control. The content intersects with legal and policy debates involving institutions such as United Nations bodies and national ministries of health in countries including France, Germany, Nigeria, and China.

Editorial and publication details

The journal is published by Wiley-Blackwell on a monthly basis and follows standard peer-review practices used by publishers such as Elsevier and Springer Nature. Editorial board members have often been affiliated with academic centers including Harvard University, University of Oxford, University of Toronto, and Karolinska Institutet, and with clinical bodies such as Royal College of Physicians and American Academy of Pediatrics. It accepts submissions for original research, systematic reviews, case reports, and letters; editorial process aligns with reporting standards promoted by organizations like Committee on Publication Ethics and International Committee of Medical Journal Editors. Print and online ISSN details align with indexing services maintained by entities including PubMed Central and CrossRef.

Abstracting and indexing

The journal is indexed in major bibliographic databases and abstracting services comparable to MEDLINE, Scopus, Embase, and PsycINFO; entries appear in catalogs managed by National Library of Medicine and citation aggregators such as Web of Science and Google Scholar. Impact metrics reported by platforms like Clarivate Analytics and rankings used in assessments by organizations such as Research Excellence Framework inform perceptions of the journal’s influence. Libraries at institutions including Yale University, University of Melbourne, Peking University and University of Cape Town carry the journal in electronic and print collections.

Reception and impact

The journal has been cited in clinical guidelines and policy statements from bodies such as World Health Organization, Centers for Disease Control and Prevention, and regional health authorities across Africa, Europe, and the Americas. Articles have contributed to debates involving public health programs like needle exchange initiatives, pre-exposure prophylaxis deployment, and screening policies in contexts related to PrEP implementation projects funded by organizations such as Bill & Melinda Gates Foundation and Wellcome Trust. The journal’s impact factor and citation counts, tracked by services like Journal Citation Reports, reflect its role in the specialist literature addressing sexually transmitted infections and HIV/AIDS.

Notable articles and controversies

Notable publications include clinical reports and surveillance studies that informed responses to antimicrobial resistance in Neisseria gonorrhoeae, diagnostic evaluations influencing adoption of nucleic acid amplification tests produced by companies such as Hologic and Cepheid, and field studies from cohorts in cities like Lagos, Mumbai, Rio de Janeiro, and Bangkok. Controversies have centered on debates over access to drug pricing and patents involving pharmaceutical firms such as Gilead Sciences and Merck & Co., ethical discussions echoing cases reviewed by institutional review boards at Cambridge University and Stanford University, and methodological disputes over observational study designs discussed at meetings like the Conference on Retroviruses and Opportunistic Infections and the European AIDS Clinical Society congress.

Category:Medical journals Category:Infectious disease journals Category:Sexology journals